$Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction$
QR Code

QR Code

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction

Aim. To study the prognostic value of myocardial blood flow (MBF) and myocardial flow reserve (MFR) parameters in patients with heart failure with preserved ejection fraction (HFpEF) and non-obstructive coronary artery disease (CAD) in risk stratification of HFpEF progression during a 12-month follo...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. V. Kopeva, A. N. Maltseva, E. V. Grakova, A. V. Mochula, M. V. Soldatenko, V. V. Kalyuzhin, K. V. Zavadovsky
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2023-04-01
Series:	Бюллетень сибирской медицины
Subjects:	heart failure preserved ejection fraction myocardial flow reserve prognosis natriuretic peptide
Online Access:	https://bulletin.ssmu.ru/jour/article/view/5130
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

Heart failure with preserved ejection fraction: the role of microvascular dysfunction
by: K. V. Kopeva, et al.
Published: (2023-01-01)

Effect of β-blocker therapy on the level soluble ST2 protein in the blood serum in patients with heart failure with preserved and mildly reduced ejection fraction
by: E. V. Grakova, et al.
Published: (2022-04-01)

Role of humoral markers in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2022-11-01)

Significance of catestatin in the pathogenesis of heart failure with preserved ejection fraction in patients with non-obstructive coronary artery disease
by: E. V. Grakova, et al.
Published: (2023-11-01)

Clinical and prognostic value of determining the level of neopterin in patients with chronic heart failure with preserved ejection fraction
by: O. S. Polunina, et al.
Published: (2018-10-01)

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

Adverse cardiovascular events in patients with coronary microvascular dysfunction: results of a 12-month follow-up with a control group
by: K. V. Kopyeva, et al.
Published: (2023-04-01)

Biomarkers in the Pathogenesis of Heart Failure with Preserved as Well as Reduced Ejection Fraction: A Cross-sectional Study
by: Sowmiya Thiyagarajan, et al.
Published: (2025-06-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Heart failure with preserved left ventricular ejection fraction in non-obstructive coronary artery disease: clinical utility of heart rate variability
by: E. V. Grakova, et al.
Published: (2023-07-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report
by: E. A. Pravkina, et al.
Published: (2023-07-01)

Prognostic value of secondary hyperaldosteronism in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-07-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

Predictors of an adverse course of heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome
by: A. T. Teplyakov, et al.
Published: (2021-07-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

Significance of inflammation markers in patients with coronary microvascular dysfunction and non-obstructive coronary artery disease
by: K. V. Kop’eva, et al.
Published: (2023-07-01)

Phenotyping of outpatients with heart failure with preserved ejection fraction and poor prognosis
by: V. N. Larina, et al.
Published: (2024-04-01)

Left atrial strain in assessing heart failure with preserved ejection fraction in hypertensive patients
by: E. S. Mazur, et al.
Published: (2022-09-01)

Decoding Survival in Elderly Acute Myocardial Infarction: The Prognostic Interplay of B-Type Natriuretic Peptide, Ejection Fraction, and Renal Function – An Observational Study
by: Rajpal Prajapati, et al.
Published: (2025-04-01)

Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-03-01)

Chatterjee phenomenon in a patient with heart failure with preserved ejection fraction: a case report
by: K. N. Vitt, et al.
Published: (2023-04-01)

Predictors of unfavorable progression and prognosis in patients with heart failure with preserved left ventricular ejection fraction
by: M. S. Sobolevskaya, et al.
Published: (2024-12-01)

Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2021-07-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01)

LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE
by: M. A. Babaev, et al.
Published: (2017-03-01)

Prevalence and echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction
by: K. G. Adamyan, et al.
Published: (2016-02-01)

Prognostic Value of the Global Left Ventricular Contractility Index in Patients with Severe Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction
by: Tony Li, et al.
Published: (2025-06-01)

The relationship between gut microbiota, chronic systemic inflammation, and endotoxemia in patients with heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2022-10-01)

The role of markers of endothelial dysfunction in the pathogenesis of coronary microvascular dysfunction in patients with non-obstructive coronary artery disease
by: K. V. Kopeva, et al.
Published: (2024-10-01)

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction
by: Giuseppe Delli Carpini, et al.
Published: (2025-07-01)

Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction
by: Z. M. Akhilgova, et al.
Published: (2020-07-01)

Novel algorithms for diagnosing heart failure with preserved ejection fraction in patients with hypertension and obesity
by: Yu. A. Vasyuk, et al.
Published: (2021-02-01)